Physician profile
Sonja Edmonds
NPI 1487679023
$281.26
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $37.42 · 2021: $45.37 · 2022: $38.19.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $56.21 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $48.42 | 2019-2020 | |
| Sobi, INC | $37.87 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $27.83 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $23.15 | 2019 | |
| Mayne Pharma Commercial LLC | $20.09 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.24 | 2020 | |
| Pfizer INC. | $18.10 | 2022 | |
| Tris Pharma INC | $15.85 | 2019 | |
| Neos Therapeutics, Lp | $15.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonja Edmonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.